IL-15 alters expression and function of the chemokine receptor CX3CR1 in human NK cells

Cellular Immunology

Volumn 230, Issue 2, 2004, Pages 99-108

  Sechler, Joan M ^a   Barlic, Jana ^a   Grivel, Jean Charles ^b   Murphy, Philip M ^a  

^a Natl Inst Allerg Infect Dis N   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Chemokine; CX3CR1; Cytokine; Fractalkine; Human NK cell; IL 15

Indexed keywords

CD56 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; FRACTALKINE; INTERLEUKIN 15; MESSENGER RNA;

ARTICLE; CALCIUM TRANSPORT; CELL CULTURE; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD56; BLOTTING, WESTERN; CALCIUM; CELL DIVISION; CHEMOTAXIS; FLOW CYTOMETRY; FLUOROMETRY; HUMANS; INTERLEUKIN-15; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 10344225071     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.10.001     Document Type: Article

References (42)

1. M.J. Robertson Role of chemokines in the biology of natural killer cells J. Leukoc. Biol. 71 2002 173 183
2. M.A. Cooper, T.A. Fehniger, and M.A. Caligiuri The biology of human natural killer-cell subsets Trends Immunol. 22 2001 633 640
3. M.K. Kennedy, M. Glaccum, S.N. Brown, E.A. Butz, J.L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C.R. Willis, K. Brasel, P.J. Morrissey, K. Stocking, J.C. Schuh, S. Joyce, and J.J. Peschon Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice J. Exp. Med. 191 2000 771 780
4. M.A. Cooper, J.E. Bush, T.A. Fehniger, J.B. VanDeusen, R.E. Waite, Y. Liu, H.L. Aguila, and M.A. Caligiuri In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells Blood 100 2002 3633 3638
5. + hematopoietic progenitor cells Blood 87 1996 2632 2640
6. J. Dunne, S. Lynch, C. O'Farrelly, S. Todryk, J.E. Hegarty, C. Feighery, and D.G. Doherty Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15 J. Immunol. 167 2001 3129 3138
7. Q.H. Nguyen, R.L. Roberts, B.J. Ank, S.J. Lin, E.K. Thomas, and E.R. Stiehm Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells Cell. Immunol. 185 1998 83 92
8. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire J. Immunol. 166 2001 6477 6482
9. M. Inngjerdingen, B. Damaj, and A.A. Maghazachi Expression and regulation of chemokine receptors in human natural killer cells Blood 97 2001 367 375
10. O. Yoneda, T. Imai, S. Goda, H. Inoue, A. Yamauchi, T. Okazaki, H. Imai, O. Yoshie, E.T. Bloom, N. Domae, and H. Umehara Fractalkine-mediated endothelial cell injury by NK cells J. Immunol. 164 2000 4055 4062
11. T. Imai, K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T.J. Schall, and O. Yoshie Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion Cell 91 1997 521 530
12. M. Nishimura, H. Umehara, T. Nakayama, O. Yoneda, K. Hieshima, M. Kakizaki, N. Dohmae, O. Yoshie, and T. Imai Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression J. Immunol. 168 2002 6173 6180
13. S.D. Voss, J. Daley, J. Ritz, and M.J. Robertson Participation of the CD94 receptor complex in costimulation of human natural killer cells J. Immunol. 160 1998 1618 1626
14. J.F. Bazan, K.B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D.R. Greaves, A. Zlotnik, and T.J. Schall A new class of membrane-bound chemokine with a CX3C motif Nature 385 1997 640 644
15. C. Hundhausen, D. Misztela, T.A. Berkhout, N. Broadway, P. Saftig, K. Reiss, D. Hartmann, F. Fahrenholz, R. Postina, V. Matthews, K.J. Kallen, S. Rose-John, and A. Ludwig The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion Blood 102 2003 1186 1195
16. C.L. Tsou, C.A. Haskell, and I.F. Charo Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine J. Biol. Chem. 276 2001 44622 44626
17. K.J. Garton, P.J. Gough, C.P. Blobel, G. Murphy, D.R. Greaves, P.J. Dempsey, and E.W. Raines Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) J. Biol. Chem. 276 2001 37993 38001
18. A.M. Fong, L.A. Robinson, D.A. Steeber, T.F. Tedder, O. Yoshie, T. Imai, and D.D. Patel Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow J. Exp. Med. 188 1998 1413 1419
19. C. Combadiere, K. Salzwedel, E.D. Smith, H.L. Tiffany, E.A. Berger, and P.M. Murphy Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1 J. Biol. Chem. 273 1998 23799 23804
20. B.W. Wong, D. Wong, and B.M. McManus Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease Cardiovasc. Pathol. 11 2002 332 338
21. K. Furuichi, T. Wada, Y. Iwata, N. Sakai, K. Yoshimoto, M. Shimizu, K. Kobayashi, K. Takasawa, H. Kida, S. Takeda, K. Matsushima, and H. Yokoyama Upregulation of fractalkine in human crescentic glomerulonephritis Nephron 87 2001 314 320
22. M.V. Volin, J.M. Woods, M.A. Amin, M.A. Connors, L.A. Harlow, and A.E. Koch Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis Am. J. Pathol. 159 2001 1521 1530
23. E. Efsen, C. Grappone, R.M. DeFranco, S. Milani, R.G. Romanelli, A. Bonacchi, A. Caligiuri, P. Failli, F. Annunziato, G. Pagliai, M. Pinzani, G. Laffi, P. Gentilini, and F. Marra Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans J. Hepatol. 37 2002 39 47
24. A. Foussat, L. Bouchet-Delbos, D. Berrebi, I. Durand-Gasselin, A. Coulomb-L'Hermine, R. Krzysiek, P. Galanaud, Y. Levy, and D. Emilie Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients Blood 98 2001 1678 1686
25. D.H. McDermott, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, M.N. Merrell, N. Epstein, A.A. Quyyumi, and P.M. Murphy Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis Circ. Res. 89 2001 401 407
26. C. Combadiere, S. Potteaux, J.L. Gao, B. Esposito, S. Casanova, E.J. Lee, P. Debre, A. Tedgui, P.M. Murphy, and Z. Mallat Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice Circulation 107 2003 1009 1016
27. L. Feng, S. Chen, G.E. Garcia, Y. Xia, M.A. Siani, P. Botti, C.B. Wilson, J.K. Harrison, and K.B. Bacon Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication Kidney Int. 56 1999 612 620
28. L.A. Robinson, C. Nataraj, D.W. Thomas, D.N. Howell, R. Griffiths, V. Bautch, D.D. Patel, L. Feng, and T.M. Coffman A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection J. Immunol. 165 2000 6067 6072
29. E. Lavergne, B. Combadiere, O. Bonduelle, M. Iga, J.L. Gao, M. Maho, A. Boissonnas, P.M. Murphy, P. Debre, and C. Combadiere Fractalkine mediates natural killer-dependent antitumor responses in vivo Cancer Res. 63 2003 7468 7474
30. J. Barlic, J.M. Sechler, and P.M. Murphy IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1 Blood 2003
31. J. Hanna, O. Wald, D. Goldman-Wohl, D. Prus, G. Markel, R. Gazit, G. Katz, R. Haimov-Kochman, N. Fujii, S. Yagel, A. Peled, and O. Mandelboim CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells Blood 102 2003 1569 1577
32. J.E. Coligan Current Protocols in Immunology 1991 Greene Pub. Associates and Wiley-Interscience New York
33. M.A. Caligiuri, A. Zmuidzinas, T.J. Manley, H. Levine, K.A. Smith, and J. Ritz Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors J. Exp. Med. 171 1990 1509 1526
34. T.A. Waldmann IL-15 in the life and death of lymphocytes: immunotherapeutic implications Trends Mol. Med. 9 2003 517 521
35. W.E. Carson, J.G. Giri, M.J. Lindemann, M.L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M.A. Caligiuri Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor J. Exp. Med. 180 1994 1395 1403
36. J.L. de Jong, N.L. Farner, B.R. Javorsky, M.J. Lindstrom, J.A. Hank, and P.M. Sondel Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy Clin. Cancer Res. 4 1998 1287 1296
37. S.J. Lin, R.L. Roberts, B.J. Ank, Q.H. Nguyen, E.K. Thomas, and E.R. Stiehm Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection J. Clin. Immunol. 18 1998 335 345
38. H. Umehara, S. Goda, T. Imai, Y. Nagano, Y. Minami, Y. Tanaka, T. Okazaki, E.T. Bloom, and N. Domae Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1 Immunol. Cell Biol. 79 2001 298 302
39. T.A. Waldmann, S. Dubois, and Y. Tagaya Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy Immunity 14 2001 105 110
40. + high stage and effector functions J. Immunol. 172 2004 88 96
41. J. Luhm, J.M. Brand, P. Koritke, M. Hoppner, H. Kirchner, and C. Frohn Large-scale generation of natural killer lymphocytes for clinical application J. Hematother. Stem Cell Res. 11 2002 651 657
42. J. Barlic, D.H. McDermott, M.N. Merrell, J. Gonzales, L.E. Via, and P.M. Murphy Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2- dependent mechanisms J. Biol. Chem. 279 2004 48520 48534